Byotrol PLC Annual General Meeting -- update on arrangements (5420E)

TIDMBYOT

RNS Number : 5420E

Byotrol PLC

06 November 2020

6 November 2020

Byotrol plc

Annual General Meeting - update on arrangements

Byotrol's AGM is to be held at the offices of finnCap Ltd, 1 Bartholomew Close, London EC1A 7BL at 11.00 am on 13 November 2020. As previously announced, shareholders should note that, due to the COVID-19 pandemic, the AGM is being held as a closed meeting. Shareholders (other than the minimum number of two required to form a quorum, as arranged by the Company) will not be able to attend and vote at the AGM in person.

The Board strongly advises shareholders to vote by proxy, appointing the chairman of the meeting, in accordance with the Notice of the AGM. In order to provide shareholders the opportunity to ask questions which would normally be put to management in person at the AGM and so that questions can be fully answered following the completion of the formal business of the AGM, the Board would request questions to be submitted in advance, before 5pm (GMT) on Thursday 12 November 2020. Questions should be sent to [e-mail] , with the word "AGM" in the title.

Questions will be considered by the Board and responses provided where practical via the Company website. In accordance with normal practice, the results of the AGM will be issued in a regulatory news announcement and posted on the Company's website.

Enquiries:

Byotrol plc

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer 01925 742 000

finnCap

   Geoff Nash/Kate Bannatyne - Corporate Finance                                 020 7220 0500 

Richard Chambers - ECM

Flagstaff Strategic and Investor Communications

   Tim Thompson/Andrea Seymour/Fergus Mellon                                020 7129 1474 

[e-mail]

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAUPGAPGUPUGGQ

(END) Dow Jones Newswires

November 06, 2020 13:41 ET (18:41 GMT)